Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Another new use claimed for raloxifene

Sep. 20, 1996

Vivus seeks approval for impotence treatment

Sep. 20, 1996

Tulane U. investigates GHRH agonists

Sep. 20, 1996

New use for 5-HT2 antagonist

Sep. 20, 1996

Troglitazone nearing launch

Sep. 20, 1996

New indications discovered for Ligand's retinoid compound, Targretin

Sep. 20, 1996

Immunex issued first patent on blood stem cell factor

Sep. 20, 1996

New indication claimed for EPO

Sep. 20, 1996

NPY antagonists from Glaxo Wellcome

Sep. 20, 1996

Bristol-Myers sets up program for heart attack prevention

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...